2027 Talent & Salary Report: Trends In The Dutch Biotech Industry

Building Competitive Hiring Strategies for 2027

Biotech companies in the Netherlands are facing a new recruitment reality. Rapid advances in cell & gene therapy, biologics, and oncology are creating demand for cross-functional experts who can operate at the intersection of science, regulation, and innovation.

Traditional hiring approaches are falling short in attracting QA, RA, Clinical and Biostatistics specialists with niche expertise. The most successful teams are rethinking how they attract, assess, and retain talent, building capabilities that combine technical excellence with compliance, speed, and innovation.

Navigating Growth and Challenges

While Dutch biotech is expanding with large-scale investments, world-class research, and government support, growth is not evenly distributed. Funding is concentrating in fewer, larger rounds, and regulatory barriers and a later-stage capital gap remain. This imbalance is mirrored in talent: the biotech talent pool shrank last year, specialists are scarce, and professionals are increasingly seeking strong compensation, impactful work, work-life balance and flexibility.